Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia - Concepedia

Concepedia

Publication | Open Access

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

DOI Full Paper Access

132

Citations

49

References

2014

Year

Anna M. Eiring, Brent D. G. Page, Ira L. Kraft, Clinton C. Mason, Nadeem A. Vellore, Diana Resetca, Matthew S. Zabriskie, T Y Zhang, Jamshid S. Khorashad, Amy Engar,

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderPharmacologyAnti-cancer AgentOncologyCell BiologyCancer ResearchTumor BiologyMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1